[1]
Norum, J. et al. 2007. Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis. Acta Oncologica. 46, 2 (Jan. 2007), 153–164. DOI:https://doi.org/10.1080/02841860601096841.